- Report
- July 2022
- 40 Pages
China
From €2810EUR$3,200USD£2,455GBP
- Report
- May 2021
- 50 Pages
China
From €2283EUR$2,600USD£1,995GBP
- Report
- April 2021
- 40 Pages
China
From €2283EUR$2,600USD£1,995GBP
- Training
- 90 Minutes
Global
- Report
- November 2022
- 54 Pages
Global
From €1756EUR$2,000USD£1,535GBP
- Report
- September 2022
- 38 Pages
Global
From €1756EUR$2,000USD£1,535GBP
- Report
- December 2022
- 30 Pages
Global
From €1756EUR$2,000USD£1,535GBP
- Report
- May 2022
- 68 Pages
Global
From €1756EUR$2,000USD£1,535GBP
- Report
- August 2025
- 157 Pages
Global
From €3644EUR$4,150USD£3,184GBP
- Report
- February 2022
- 84 Pages
Global
From €3200EUR$3,904USD£2,894GBP
- Report
- February 2026
Global
From €3503EUR$3,990USD£3,061GBP
- Report
- February 2026
Global
From €3503EUR$3,990USD£3,061GBP
- Report
- February 2026
United States
From €3503EUR$3,990USD£3,061GBP
- Report
- February 2026
North America
From €3503EUR$3,990USD£3,061GBP
- Report
- February 2026
Europe
From €3503EUR$3,990USD£3,061GBP
- Report
- February 2026
Middle East
From €3503EUR$3,990USD£3,061GBP
- Report
- February 2026
Asia Pacific
From €3503EUR$3,990USD£3,061GBP
- Report
- February 2026
United States
From €3503EUR$3,990USD£3,061GBP
- Report
- February 2026
United Kingdom
From €3503EUR$3,990USD£3,061GBP
- Report
- February 2026
North America
From €3503EUR$3,990USD£3,061GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more